Literature DB >> 12085969

Integrins and prostate cancer metastases.

M Fornaro1, T Manes, L R Languino.   

Abstract

Integrins have emerged as modulators of a variety of cellular functions. They have been implicated in cell migration, survival, normal and aberrant cellular growth, differentiation, gene expression, and modulation of intracellular signal transduction pathways. In this review article, the structural and functional characteristics of integrins, their expression and their potential role in prostate cancer metastases will be discussed.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12085969     DOI： 10.1023/a:1015547830323

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


  58 in total

1.  Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.

Authors:  Amrita Singh; Carmine Fedele; Huimin Lu; Marja T Nevalainen; James H Keen; Lucia R Languino
Journal:  Mol Cancer Res       Date:  2016-07-20       Impact factor: 5.852

2.  Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

Authors:  Deborah A Bradley; Stephanie Daignault; Charles J Ryan; Robert S Dipaola; Kathleen A Cooney; David C Smith; Eric Small; Paul Mathew; Mitchell E Gross; Mark N Stein; Alice Chen; Kenneth J Pienta; June Escara-Wilke; Gerald Doyle; Mahmoud Al-Hawary; Evan T Keller; Maha Hussain
Journal:  Invest New Drugs       Date:  2010-03-25       Impact factor: 3.850

3.  Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Zhao-Zhu Zeng; Kevin S Fay; Evan D Staszewski; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2010-03-26       Impact factor: 5.150

4.  Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.

Authors:  Jong-Wei Hsu; Sayeda Yasmin-Karim; Michael R King; Joel C Wojciechowski; Deanne Mickelsen; Martha L Blair; Huei-Ju Ting; Wen-Lung Ma; Yi-Fen Lee
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Authors:  Michael O Ports; Ray B Nagle; Gerald D Pond; Anne E Cress
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

6.  Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.

Authors:  Steven R Barthel; Jacyln D Gavino; Georg K Wiese; Jennifer M Jaynes; Javed Siddiqui; Charles J Dimitroff
Journal:  Glycobiology       Date:  2008-07-22       Impact factor: 4.313

Review 7.  Integrins in prostate cancer progression.

Authors:  Hira Lal Goel; Jing Li; Sophia Kogan; Lucia R Languino
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

8.  Role of proprotein convertases in prostate cancer progression.

Authors:  Frédéric Couture; François D'Anjou; Roxane Desjardins; François Boudreau; Robert Day
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

9.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

10.  Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.

Authors:  Marco Trerotola; Danielle L Jernigan; Qin Liu; Javed Siddiqui; Alessandro Fatatis; Lucia R Languino
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.